Akso Health director files initial Form 3

Akso Health Group director Liu Zhe submitted an initial insider ownership report on Form 3.

Rhea-AI Filing Summary

Akso Health Group director Liu Zhe submitted an initial insider ownership report on Form 3. The filing lists Liu as a director but shows no reported transactions, meaning it simply establishes Liu’s status as an insider for future ownership and trading disclosures.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Akso Health Group (AHG) Form 3 filing for Liu Zhe show?

The Form 3 shows that Liu Zhe is a director of Akso Health Group. It is an initial insider ownership report and, in this case, lists no transactions, serving mainly to register Liu as an insider for future disclosures.

Did Liu Zhe buy or sell Akso Health Group (AHG) shares in this Form 3?

No, this Form 3 for Akso Health Group director Liu Zhe reports zero buy or sell transactions. It is strictly an initial ownership statement without any insider trading activity disclosed in the summary data.

What insider role does Liu Zhe hold at Akso Health Group (AHG)?

Liu Zhe is identified as a director of Akso Health Group in the Form 3. The filing indicates Liu is not listed as an officer and not marked as a ten percent owner in the summary data provided.

Does the Akso Health Group (AHG) Form 3 for Liu Zhe include derivative securities?

No derivative securities are listed for Liu Zhe in the provided Form 3 summary. The derivative section is empty, indicating no reported options, warrants, or other derivative positions for this insider in this particular filing.

What trading direction is indicated in the Akso Health Group (AHG) Form 3 for Liu Zhe?

The Form 3 summary shows no buy or sell activity, with net trading direction described as neutral. This reflects that the filing is an initial ownership report without any insider transactions recorded in the summary metrics.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 10:00 AM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Liu Zhe

(Last) (First) (Middle)

ROOM 8201-4-4(A), 2ND FLOOR

QIANTONGYUAN BUILDING

(Street)

QINGDAO 00000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Akso Health Group [ AHG ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	Zhe Liu	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)